VONDRÁČEK, Jan, Jiří ŠTIKA, Karel SOUČEK, Kateřina MINKSOVÁ, Luděk BLÁHA, Jiřina HOFMANOVÁ and Alois KOZUBÍK. Inhibitors of arachidonic acid metabolism potentiate tumour necrosis factor-alpha-induced apoptosis in HL-60 cells. European Journal of Pharmacology. Amsterdam: Elsevier Science B.V., 2001, vol. 424, No 1, p. 1-11. ISSN 0014-2999.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Inhibitors of arachidonic acid metabolism potentiate tumour necrosis factor-alpha-induced apoptosis in HL-60 cells
Authors VONDRÁČEK, Jan, Jiří ŠTIKA, Karel SOUČEK, Kateřina MINKSOVÁ, Luděk BLÁHA, Jiřina HOFMANOVÁ and Alois KOZUBÍK.
Edition European Journal of Pharmacology, Amsterdam, Elsevier Science B.V. 2001, 0014-2999.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 2.164
RIV identification code RIV/00216224:14310/01:00005239
Organization unit Faculty of Science
UT WoS 000170224200001
Changed by Changed by: Mgr. Jiří Štika, Ph.D., učo 8741. Changed: 8/1/2002 16:37.
Abstract
We investigated whether and how could various modulators of arachidonic acid metabolism affect apoptosis induced by tumour necrosis factor-alpha (TNF-alpha) in human myeloid leukaemia HL-60 cells. These included arachinonyltrifluoromethyl ketone (AACOCF3; cytosolic phospholipase A2 inhibitor), indomethacin (cyclooxygenase inhibitor), MK-886 (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethyl propanoic acid; 5-lipoxygenase-activating protein inhibitor), nordihydroguaiaretic acid (general lipoxygenase inhibitor), and arachidonic acid itself. Incubation of HL-60 cells with nordihydroguaiaretic acid resulted in apoptosis and it was characterised by mitochondria membrane depolarisation, release of cytochrome c from mitochondria into cytosol and activation of caspase-3. Indomethacin and nordihydroguaiaretic acid synergistically potentiated TNF-alpha-induced apoptosis, while arachidonic acid, AACOCF3 and MK-886 did not modulate its effects. Furthermore, indomethacin potentiated apoptosis in cells treated with a differentiating agent, all-trans retinoic acid, which induces resistance to TNF-alpha. However, the observed effects were probably not associated either with the cyclooxygenase- or lipoxygenase-dependent activities of indomethacin and nordihydroguaiaretic acid, respectively. Since indomethacin may reportedly activate peroxisome proliferator-activated receptors (PPARs), the effects of specific ligands of PPARs on apoptosis were studied as well. It was found that selective PPARs ligands had no effects on TNF-alpha-induced apoptosis. The findings suggest that arachidonic acid metabolism does not play a key role in regulation of apoptosis induced by TNF-alpha in the present model. Nevertheless, our data raise the possibility that indomethacin could potentially be used to improve the treatment of human myeloid leukaemia.
Links
GA312/98/P011, research and development projectName: Úloha metabolismu kyseliny arachidonové v apoptóze indukované TNF-alfa a anti-Fas v průběhu diferenciace buněk lidské leukemické linie HL-60
GA524/99/0694, research and development projectName: Vysoce nenasycené mastné kyseliny a cytokiny - jejich úloha pro zachování homeostázy na úrovni buněčných populací
PrintDisplayed: 4/5/2024 04:55